| 1 |
Liquid Orals |
B-Complex with L-Lysine Syrup (For therapeutic use) |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Thiamine Hydrochloride |
I.P. |
2 mg |
| Riboflavine Sodium Phosphate |
I.P. |
2.5 mg |
| Pyridoxine Hydrochloride |
I.P. |
0.75 mg |
| Nicotinamide |
I.P. |
15 mg |
| D-Panthenol |
I.P. |
3 mg |
| Cyanocobalamin |
I.P. |
2 mcg |
| Lysine Hydrochloride |
I.P. |
375 mg |
| Zinc Gluconate (eq. to elemental Zinc) |
USP |
5 mg |
| Sorbitol Solution 70% (Non-crystallizing) |
I.P. |
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Excipients |
|
q.s. |
| Colour: Approved colour used |
|
|
|
| 2 |
Liquid Orals |
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Dextromethorphan Hydrobromide |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved Colour used |
|
|
|
| 3 |
Liquid Orals |
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Dextromethorphan Hydrobromide |
I.P. |
15 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Phenylepherine Hydrochloride |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| In a palatable sugar-free base |
|
q.s. |
| Approved Colour used |
|
|
|
| 4 |
Liquid Orals |
Domperidone Oral Drop |
| Composition |
Standard |
Quantity (per 1 ml) |
| Each 1 ml contains : |
|
|
| Domperidone |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved Colour used |
|
|
|
| 5 |
Liquid Orals |
Ambroxol HCl, Dextromethorphan HBR, Phenylepherine HCl, Chlorpheniramine Maleate and Menthol Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ambroxol Hydrochloride |
I.P. |
15 mg |
| Dextromethorphan Hydrobromide |
I.P. |
10 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Menthol |
I.P. |
1.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 6 |
Liquid Orals |
Dried Aluminium Hydroxide Gel, Oxetacaine and Magnesium Hydroxide Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Aluminium Hydroxide (added as Dried Aluminium Hydroxide Gel 380 mg) |
I.P. |
0.291 gm |
| Oxetacaine |
B.P. |
10 mg |
| Magnesium Hydroxide (as Magnesium Hydroxide Paste) |
I.P. |
98 mg |
| Excipients |
|
q.s. |
| In a flavoured palatable base |
|
q.s. |
| Approved colour used |
|
|
|
| 7 |
Liquid Orals |
Levosalbutamol Sulphate, Ambroxol Hydrochloride, and Guaiphenesin Oral Drops |
| Composition |
Standard |
Quantity (per 1 ml) |
| Each 1 ml contains : |
|
|
| Levosalbutamol Sulphate (eq. to Levosalbutamol) |
I.P. |
0.25 mg |
| Ambroxol Hydrochloride |
I.P. |
7.5 mg |
| Guaiphenesin |
I.P. |
12.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved Colour used |
|
|
|
| 8 |
Liquid Orals |
Cyproheptadine Hydrochloride and Tricholine Citrate Drops |
| Composition |
Standard |
Quantity (per 1 ml) |
| Each 1 ml contains : |
|
|
| Cyproheptadine Hydrochloride |
I.P. |
2 mg |
| Tricholine Citrate (65%) |
|
55 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved Colour used |
|
|
|
| 9 |
Liquid Orals |
Ursodeoxycholic Acid Suspension 250mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ursodeoxycholic Acid |
I.P. |
250 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 10 |
Liquid Orals |
Ursodeoxycholic Acid Suspension 125mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ursodeoxycholic Acid |
I.P. |
125 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 11 |
Liquid Orals |
Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
125 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
0.5 mg |
| Sodium Citrate |
I.P. |
60 mg |
| Menthol |
I.P. |
1 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 12 |
Liquid Orals |
Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml (1 teaspoonful approx.) contains : |
|
|
| Milk of Magnesia |
I.P. |
3.75 ml |
| Liquid Paraffin |
I.P. |
1.25 ml |
| Sodium Picosulfate |
B.P. |
3.33 mg |
| Excipients |
|
q.s. |
| Indication |
|
For symptomatic treatment of constipation in adults |
| Dosage |
|
As directed by the physician |
| Approved colour used |
|
|
|
| 13 |
Liquid Orals |
Ferric Ammonium Citrate, Folic acid and Vitamin B12 Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ferric Ammonium Citrate (eq. to Elemental Iron) |
I.P. |
160 mg (Elemental Iron 32.80 mg) |
| Folic Acid |
I.P. |
0.5 mg |
| Cyanocobalamin |
I.P. |
7.5 mcg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Colour |
|
Approved colour used |
|
| 14 |
Liquid Orals |
Ofloxacin & Metronidazole Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ofloxacin |
I.P. |
100 mg |
| Metronidazole Benzoate (eq. to Metronidazole) |
I.P. |
200 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 15 |
Liquid Orals |
Azithromycin Oral Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Azithromycin (as dehydrate) eq. to Azithromycin anhydrous |
I.P. |
100 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 16 |
Liquid Orals |
Dill Oil, Fennel Oil with Simethicone Oral Drops |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Dill Oil |
B.P. |
0.005 ml |
| Fennel Oil |
USP |
0.0007 ml |
| Simethicone Emulsion (30%) eq. to Simethicone |
USP |
40 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 17 |
Liquid Orals |
Zinc Gluconate Oral Solution |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Zinc Gluconate (eq. to elemental Zinc) |
B.P. |
20 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 18 |
Liquid Orals |
Paracetamol Suspension I.P. 500 mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 19 |
Liquid Orals |
Levetiracetam Oral Solutions I.P 500mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Levetiracetam |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 20 |
Liquid Orals |
Ambroxol Hydrochloride Syrup 30mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ambroxol Hydrochloride |
I.P. |
30 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 21 |
Liquid Orals |
Ranitidine Oral Solution I.P |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ranitidine Hydrochloride (eq. to Ranitidine) |
I.P. |
75 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 22 |
Liquid Orals |
Ibuprofen and Paracetamol Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ibuprofen |
I.P. |
100 mg |
| Paracetamol |
I.P. |
162.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 23 |
Liquid Orals |
Hydroxyzine Oral Solution I.P. |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Hydroxyzine Hydrochloride |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 24 |
Liquid Orals |
Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
125 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
0.5 mg |
| Sodium Citrate |
I.P. |
60 mg |
| Menthol |
I.P. |
1 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 25 |
Liquid Orals |
Fexofenadine Hydrochloride Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Fexofenadine Hydrochloride |
I.P. |
60 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 26 |
Liquid Orals |
Fexofenadine Hydrochloride Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Fexofenadine Hydrochloride |
I.P. |
30 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 27 |
Liquid Orals |
Phenylepherine Hydrochloride & Chlorpheniramine Maleate Syrup I.P |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 28 |
Liquid Orals |
Iron, Vitamin B12 and Folic Acid Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ferric Ammonium Citrate (eq. to elemental Iron) |
I.P. |
110.55 mg |
| Folic Acid |
I.P. |
1.5 mg |
| Cyanocobalamin |
I.P. |
15 mcg |
| In a flavoured syrupy base |
|
q.s. |
| Excipients |
|
q.s. |
| Colour: Approved colour used |
|
|
|
| 29 |
Liquid Orals |
Pyridoxine Hydrochloride, Nicotinamide, Cyanocobalamin and Lysine Hydrochloride Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Pyridoxine Hydrochloride |
I.P. |
0.75 mg |
| Nicotinamide |
I.P. |
15 mg |
| Cyanocobalamin |
I.P. |
2 mcg |
| Lysine Hydrochloride |
I.P. |
37.5 mg |
| In a flavoured syrupy base |
|
q.s. |
| Excipients |
|
q.s. |
| Colour: Approved colour used |
|
|
|
| 30 |
Liquid Orals |
Liquid Paraffin & Milk of Magnesia Suspension |
| Composition |
Standard |
Quantity (per 15 ml) |
| Each 15 ml contains : |
|
|
| Liquid Paraffin |
I.P. |
3.75 ml |
| Milk of Magnesia |
I.P. |
11.25 ml |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved colour used |
|
|
|
| 31 |
Liquid Orals |
Promethazine Syrup I.P |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Promethazine Hydrochloride |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved colour used |
|
|
|
| 32 |
Liquid Orals |
Levocetirizine Dihydrochloride Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Levocetirizine Dihydrochloride |
I.P. |
2.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved colour used |
|
|
|
| 33 |
Liquid Orals |
Levodropropizine & Chlorpheniramine Maleate Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Levodropropizine |
I.P. |
30 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 34 |
Liquid Orals |
Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate and Menthol Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Diphenhydramine Hydrochloride |
I.P. |
14.08 mg |
| Ammonium Chloride |
I.P. |
138 mg |
| Sodium Citrate |
I.P. |
57.03 mg |
| Menthol |
I.P. |
1.14 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 35 |
Liquid Orals |
Potassium Citrate, Magnesium Citrate & Pyridoxine HCl Oral Solution |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Potassium Citrate |
I.P. |
1100 mg |
| Magnesium Citrate |
USP |
375 mg |
| Pyridoxine Hydrochloride |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 36 |
Liquid Orals |
Calcium, Magnesium, Zinc & Vitamin D3 Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Calcium Carbonate (eq. to elemental Calcium) |
I.P. |
625 mg |
| Magnesium Hydroxide (eq. to elemental Magnesium) |
I.P. |
75 mg |
| Zinc Gluconate (eq. to elemental Zinc) |
USP |
2 mg |
| Vitamin D3 |
I.P. |
200 I.U. |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 37 |
Liquid Orals |
Sodium Alginate, Sodium Bicarbonate and Calcium Carbonate Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Sodium Alginate |
I.P. |
250 mg |
| Sodium Bicarbonate |
I.P. |
133.5 mg |
| Calcium Carbonate |
I.P. |
80 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 38 |
Liquid Orals |
Dried Aluminium Hydroxide, Magnesium Hydroxide, Simethicone Suspension |
| Composition |
Standard |
Quantity (per 10 ml) |
| Each 10 ml contains : |
|
|
| Dried Aluminium Hydroxide |
I.P. |
250 mg |
| Magnesium Hydroxide |
I.P. |
250 mg |
| Simethicone |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 39 |
Liquid Orals |
Chlorhexidine Gluconate Mouth Wash IP |
| Composition |
Standard |
Quantity |
| Chlorhexidine Gluconate |
I.P. |
0.2% w/v |
| In a pleasantly flavoured syrupy base |
|
q.s. |
| Approved colour used |
|
|
|
| 40 |
Liquid Orals |
Paracetamol, Cetirizine HCl, Phenylephrine HCl and Menthol Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
250 mg |
| Cetirizine Hydrochloride |
I.P. |
2.5 mg |
| Phenylephrine Hydrochloride |
I.P. |
2.5 mg |
| Menthol |
I.P. |
1 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved colour used |
|
|
|
| 41 |
Liquid Orals |
Cetirizine HCl, Phenylephrine HCl and Paracetamol Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Cetirizine Hydrochloride |
I.P. |
2.5 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Paracetamol |
I.P. |
125 mg |
| Excipients |
|
q.s. |
| In a flavoured syrupy base |
|
q.s. |
| Approved colour used |
|
|
|
| 42 |
Liquid Orals |
Levocloperastine Fendizoate Oral Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Levocloperastine Fendizoate (eq. to Levocloperastine Hydrochloride) |
|
20 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 43 |
Liquid Orals |
Paracetamol, Phenylephrine & Chlorpheniramine Maleate Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
250 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 44 |
Liquid Orals |
Fungal Diastase and Pepsin Syrup |
| Composition |
Standard |
Quantity (per 15 ml) |
| Each 15 ml contains : |
|
|
| Fungal Diastase (1:1200) (Derived from Aspergillus oryzae, digest not less than 60 gm of cooked starch) |
I.P. |
50 mg |
| Pepsin (1:3000) (Digest not less than 60 gm of coagulated egg albumin) |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| In a Flavoured Palatable base |
|
q.s. |
| Approved Colour used |
|
|
Dosage:
Adult: One teaspoonful immediately after the meal.
Children: Half the adult dose.
As directed by the physician.
|
|
| 45 |
Liquid Orals |
Sucralfate and Oxetacaine Suspension |
| Composition |
Standard |
Quantity (per 10 ml) |
| Each 10 ml contains : |
|
|
| Sucralfate |
USP |
1000 mg |
| Oxetacaine |
B.P. |
20 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 46 |
Liquid Orals |
Lactulose Oral Solution U.S.P. |
| Composition |
Standard |
Quantity (per 15 ml) |
| Each 15 ml contains : |
|
|
| Lactulose Concentrate (eq. to Lactulose 66% w/v) |
USP |
10 gm |
| In a flavoured syrup base |
|
q.s. |
| Excipients |
|
q.s. |
| Approved colour used |
|
|
|
| 47 |
Liquid Orals |
Mefenamic Acid and Paracetamol Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Mefenamic Acid |
I.P. |
100 mg |
| Paracetamol |
I.P. |
250 mg |
| In Flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 48 |
Liquid Orals |
Di-Sodium Hydrogen Citrate Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Di-Sodium Hydrogen Citrate |
B.P. |
1.37 gm |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 49 |
Liquid Orals |
Ofloxacin, Metronidazole Benzoate and Simethicone Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ofloxacin |
I.P. |
50 mg |
| Metronidazole Benzoate (eq. to Metronidazole) |
I.P. |
120 mg |
| Simethicone |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 50 |
Liquid Orals |
Sodium Picosulfate Oral Solution B.P. |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml (1 teaspoonful approx.) contains : |
|
|
| Sodium Picosulfate |
B.P. |
5 mg |
| Excipients |
|
q.s. |
Dosage: As directed by the physician.
Approved Colour used
|
|
| 51 |
Liquid Orals |
Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml (1 teaspoonful approx.) contains : |
|
|
| Sodium Picosulfate |
B.P. |
33.3 mg |
| Liquid Paraffin |
I.P. |
1.25 ml |
| Milk of Magnesia |
I.P. |
3.75 ml |
| Excipients |
|
q.s. |
Indication: For symptomatic treatment of constipation in adults.
Dosage: As directed by the physician.
Approved Colour used
|
|
| 52 |
Liquid Orals |
Dried Aluminium Hydroxide, Magnesium Hydroxide, Simethicone and Oxetacaine Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Dried Aluminium Hydroxide Gel (eq. to Aluminium Hydroxide) |
I.P. |
600 mg |
| Magnesium Hydroxide |
I.P. |
300 mg |
| Simethicone |
I.P. |
25 mg |
| Oxetacaine |
B.P. |
10 mg |
| Purified Water |
I.P. |
q.s. |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 53 |
Liquid Orals |
Ofloxacin Oral Suspension I.P. 100mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ofloxacin |
I.P. |
100 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 54 |
Liquid Orals |
Ondansetron Oral Solution I.P. 2 mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ondansetron Hydrochloride (eq. to Ondansetron) |
I.P. |
2 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 55 |
Liquid Orals |
Paracetamol Paediatric Oral Suspension I.P. 250mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
250 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 56 |
Liquid Orals |
Paracetamol Paediatric Oral Suspension I.P. 125mg |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Paracetamol |
I.P. |
125 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 57 |
Liquid Orals |
Magaldrate and Simethicone Oral Suspension I.P. |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Magaldrate (Anhydrous) |
I.P. |
400 mg |
| Simethicone |
I.P. |
60 mg |
| In a suspension base |
|
|
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 58 |
Liquid Orals |
Mefenamic Acid and Paracetamol Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Mefenamic Acid |
I.P. |
50 mg |
| Paracetamol |
I.P. |
125 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 59 |
Liquid Orals |
Vitamin D3 oral Solution 60000 I.U (Nano Shot) |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Cholecalciferol (Vitamin D3) (In nano droplet form) |
I.P. |
60,000 I.U. |
| In a flavoured sorbitol base |
|
q.s. |
| Colour: Tartrazine Supra |
|
|
|
| 60 |
Liquid Orals |
Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ambroxol Hydrochloride |
I.P. |
15 mg |
| Levosalbutamol Sulphate (eq. to Levosalbutamol) |
I.P. |
0.50 mg |
| Guaiphenesin |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 61 |
Liquid Orals |
Lycopene Enriched with Antioxidants, Multivitamin and Multimineral Syrup |
| Composition |
Standard |
Quantity (per 10 ml) |
| Each 10 ml contains : |
|
|
| Lycopene 10% |
USP |
2000 mcg |
| Niacinamide |
I.P. |
25 mg |
| Folic Acid |
I.P. |
100 mcg |
| Selenium Dioxide Monohydrate (eq. to Selenium) |
B.P. |
35 mcg |
| Zinc (as Zinc Gluconate USP) |
|
3 mg |
| Iodine (as Potassium Iodide IP) |
|
100 mcg |
| Copper (as Cupric Sulphate USP) |
|
500 mcg |
| Vitamin B12 |
I.P. |
1 mcg |
| Vitamin B6 |
I.P. |
1.5 mg |
| Excipients |
|
q.s. |
| In a flavoured base |
|
q.s. |
| Appropriate overages of vitamins added to compensate for any loss on storage |
|
|
| Approved colour used |
|
|
|
| 62 |
Liquid Orals |
Aceclofenac and Paracetamol Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Aceclofenac |
I.P. |
50 mg |
| Paracetamol |
I.P. |
125 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 63 |
Liquid Orals |
Vitamin D3 (Cholecalciferol) Drops |
| Composition |
Standard |
Quantity (per ml) |
| Each 1 ml contains : |
|
|
| Vitamin D3 (Cholecalciferol) |
I.P. |
800 IU |
| Excipients |
|
q.s. |
| In a flavoured Palatable base |
|
q.s. |
| Approved Colour used |
|
|
|
| 64 |
Liquid Orals |
Fungal Diastase and Pepsin syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
Fungal Diastase (1:1200) (Derived from Aspergillus oryzae, digest not less than 60 gm of cooked starch) |
I.P. |
50 mg |
Pepsin (1:3000) (Digest not less than 60 gm of coagulated egg albumin) |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| In a Flavoured Palatable base |
|
q.s. |
| Approved Colour used |
|
|
Dosage:
Adult: One teaspoonful immediately after the meal.
Children: Half the adult dose.
As directed by the physician.
|
|
| 65 |
Liquid Orals |
Azithromycin Oral Suspension I.P. |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Azithromycin Dihydrate (eq. to anhydrous Azithromycin) |
I.P. |
200 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 66 |
Liquid Orals |
Ferrous Ascorbate And Folic Acid Suspension |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ferrous Ascorbate (eq. to elemental iron) |
|
30 mg |
| Folic Acid |
I.P. |
550 mcg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 67 |
Liquid Orals |
Terbutaline Sulphate, Bromhexine Hydrochloride, Guiaphenesin and Menthol Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml (one teaspoonful) contains : |
|
|
| Terbutaline Sulphate |
I.P. |
1.25 mg |
| Bromhexine Hydrochloride |
I.P. |
4 mg |
| Guaiphenesin |
I.P. |
50 mg |
| Menthol |
I.P. |
1 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 68 |
Liquid Orals |
Piracetam Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Piracetam |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 69 |
Liquid Orals |
Montelukast Sodium and Levocetirizine Dihydrochloride Suspension (For Paediatric Use Only) |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Montelukast Sodium (eq. to Montelukast) |
I.P. |
4 mg |
| Levocetirizine Dihydrochloride |
I.P. |
2.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Colour: Approved colour used |
|
|
|
| 70 |
Liquid Orals |
Ambroxol Hydrochloride, Levocetirizine Hydrochloride, Guaiphenesin and Menthol Syrup |
| Composition |
Standard |
Quantity |
| Each 5 ml contains: |
|
|
| Ambroxol Hydrochloride |
I.P. |
15 mg |
| Levocetirizine Hydrochloride |
I.P. |
2.5 mg |
| Guaiphenesin |
I.P. |
50 mg |
| Menthol |
I.P. |
1 mg |
| In a flavoured syrup base |
|
q.s. |
| Excipients |
|
q.s. |
| Colour |
|
Approved colour used |
|
| 71 |
Liquid Orals |
Magaldrate and Simethicone Oral Suspension U.S.P. |
| Composition |
Standard |
Quantity |
| Each 5 ml contains: |
|
|
| Magaldrate (anhydrous) |
I.P. |
400 mg |
| Simethicone |
I.P. |
20 mg |
| Sorbitol Solution 70% (Non-crystallizing) |
I.P. |
q.s. |
| Purified Water |
I.P. |
q.s. |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
Dosage:
Adults & Children over 12 years: 1–2 teaspoonfuls between meals & at bedtime.
Children 5–12 years: Half of the above dose or as directed by the physician.
|
|
| 72 |
Liquid Orals |
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup |
| Composition |
Standard |
Quantity |
| Each 5 ml (one teaspoonful) contains : |
|
|
| Dextromethorphan Hydrobromide |
I.P. |
10 mg |
| Chlorpheniramine Maleate |
I.P. |
2 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
Dosage:
Adults: 10 ml, 3–4 times a day
Children (2–6 years): 2.5 ml, 3–4 times a day
Children (6–12 years): 5 ml, 3–4 times a day
|
|
| 73 |
Liquid Orals |
Cyproheptadine Hydrochloride and Tricholine Citrate Syrup |
| Composition |
Standard |
Quantity |
| Each 5 ml contains : |
|
|
| Cyproheptadine Hydrochloride (anhydrous) |
I.P. |
2 mg |
| Tricholine Citrate (65%) |
|
275 mg |
| Sorbitol Solution 70% (Non-crystallizing) |
I.P. |
q.s. |
| Excipients |
|
q.s. |
| In a Flavoured Syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 74 |
Liquid Orals |
Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin and Menthol Syrup |
| Composition |
Standard |
Quantity |
| Each 5 ml contains : |
|
|
| Terbutaline Sulphate |
I.P. |
2.5 mg |
| Ambroxol Hydrochloride |
I.P. |
30 mg |
| Guaiphenesin |
I.P. |
100 mg |
| Menthol |
I.P. |
2.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 75 |
Liquid Orals |
Deflazacort Oral Suspension |
| Composition |
Standard |
Quantity |
| Each 5 ml contains : |
|
|
| Deflazacort |
|
6 mg |
| In a flavoured syrup base |
|
q.s. |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 76 |
Liquid Orals |
Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup |
| Composition |
Standard |
Quantity |
| Each 5 ml contains : |
|
|
| Ambroxol Hydrochloride |
I.P. |
30 mg |
| Levosalbutamol Sulphate eq. to Levosalbutamol |
I.P. |
1 mg |
| Guaiphenesin |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved colour used |
|
|
|
| 77 |
Liquid Orals |
Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol syrup Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Paracetamol |
I.P. |
125 mg |
| Phenylephrine Hydrochloride |
I.P. |
5 mg |
| Chlorpheniramine Maleate |
I.P. |
0.5 mg |
| Sodium Citrate |
I.P. |
60 mg |
| Menthol |
I.P. |
1 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|
| 78 |
Liquid Orals |
Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup |
| Composition |
Standard |
Quantity (per 5 ml) |
| Each 5 ml contains : |
|
|
| Ambroxol Hydrochloride |
I.P. |
15 mg |
| Terbutaline Sulphate |
I.P. |
1.25 mg |
| Guaiphenesin |
I.P. |
50 mg |
| Menthol |
I.P. |
2.5 mg |
| Excipients |
|
q.s. |
| In a flavoured syrup base |
|
q.s. |
| Approved Colour used |
|
|
|